Bellevue Group Ag Astrazeneca PLC Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Astrazeneca PLC stock. As of the latest transaction made, Bellevue Group Ag holds 33,500 shares of AZN stock, worth $2.31 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

33,500

Previous 42,200 20.62%

Holding current value

$2.31 Million

Previous $3.29 Million 20.69%

% of portfolio

0.04%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $667,029 - $762,294	-8,700 Reduced 20.62%	33,500 $2.61 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.27 Million - $1.54 Million	19,000 Added 81.9%	42,200 $3.29 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $1.73 Million - $1.98 Million	-28,400 Reduced 55.04%	23,200 $1.57 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $2.04 Million - $2.29 Million	-33,000 Reduced 39.01%	51,600 $3.48 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $64,849 - $71,700	-1,000 Reduced 1.17%	84,600 $5.73 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $978,740 - $1.06 Million	14,000 Added 19.55%	85,600 $6.13 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $195,765 - $221,959	3,100 Added 4.53%	71,600 $4.97 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $1.31 Million - $1.7 Million	24,100 Added 54.28%	68,500 $4.64 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $2.26 Million - $5.78 Million	-42,600 Reduced 48.97%	44,400 $2.46 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $154,076 - $184,964	-2,600 Reduced 2.9%	87,000 $5.75 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $1.71 Million - $2.05 Million	30,600 Added 51.86%	89,600 $5.94 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $3.19 Million - $3.77 Million	59,000 New	59,000 $3.44 Million

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Astrazeneca PLC Transaction History